This is a resubmission of an application for a multiple disciplinary drug abuse research training program, entitled Training in Neurobehavior/Neuroimmune Addiction Research, which is a combined program consisting of the Training in Drug Abuse and Neurobehavioral Pharmacology T32 DA07097-20) and Training in Psychoneuroimmunology and Substance Abuse T32 DA07239-10) grants. Combining these programs is a logical extension of significant interactions manifest as combined research retreats, existing and planned collaborations between two or more laboratories, overlapping research interests, NIDA/NIH research support and joint advisorships and mentorships. Its goal is to train researchers who will be able to study problems of addictive diseases at either fundamental levels of analyses or more global levels (e.g. cellular biology or multiple systems/behavioral) as their primary focus but to be able to discuss, integrate and collaborate with others working at other levels of analyses. For example, knowledge that, or even how an addictive drug affects immune system cells in culture, without regard to its influence upon systems which function in an integrative fashion (e.g. CNS and endocrine system) may have little relevance to the in vivo situation. Add to this the secondary (e.g. adaption) or tertiary consequences (e.g. withdrawal stress) and the complexity of the causes, consequences and prevention or treatment intervention strategies requires that people trained as the next generation of researchers in addictive diseases be schooled broadly, as well as narrowly. Training will emphasize mastery of one or two knowledge bases and research methodologies, coupled with exposure to and collaboration with faculty and trainees with overlapping and more diverse approaches to a global problem, such as abuse of and addiction to a particular class of drugs. To accomplish this, educational structure includes a formal, tailored curriculum, specific courses in Neuro-Immune Interactions, and Neuropsychopharmacology, an active seminar and conference schedule and research linkages with faculty across the relevant disciplines. The primary training faculty includes scientists with M.D. and/or Ph.D. degrees in pharmacology, psychology, immunology and neuroscience who are well-funded and respected researchers and who are conversant with a wide array of research methodologies. This training program will develop scientists who have the knowledge and experience for research careers similar to trainees who have already completed training under the more senior faculty and hold positions in academic and government institutions or industry. The request is for 11 predoctoral positions and 10 postdoctoral positions in the combined program, a reduction in overall numbers from the previous request. We envision the combined program will strengthen and broaden the modicum of success each already enjoys in its own right.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Institutional National Research Service Award (T32)
Project #
5T32DA007097-22
Application #
6515447
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Babecki, Beth
Project Start
1979-01-01
Project End
2006-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
22
Fiscal Year
2002
Total Cost
$873,038
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Other Clinical Sciences
Type
Schools of Veterinary Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Clayton, Jonathan B; Al-Ghalith, Gabriel A; Long, Ha Thang et al. (2018) Associations Between Nutrition, Gut Microbiome, and Health in A Novel Nonhuman Primate Model. Sci Rep 8:11159
Laudenbach, Megan; Baruffaldi, Federico; Robinson, Christine et al. (2018) Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose. Sci Rep 8:5508
Harris, Andrew C; Muelken, Peter; Haave, Zach et al. (2018) Propylene glycol, a major electronic cigarette constituent, attenuates the adverse effects of high-dose nicotine as measured by intracranial self-stimulation in rats. Drug Alcohol Depend 193:162-168
Harris, Andrew C; Muelken, Peter; Smethells, John R et al. (2018) Effects of nicotine-containing and ""nicotine-free"" e-cigarette refill liquids on intracranial self-stimulation in rats. Drug Alcohol Depend 185:1-9
Martin, Jessica L; Mendonça, Luiza M; Marusinec, Rachel et al. (2018) Critical Role of the Human T-Cell Leukemia Virus Type 1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle Assembly. J Virol 92:
Leavens, Eleanor L S; Meier, Ellen; Tackett, Alayna P et al. (2018) The impact of a brief cessation induction intervention for waterpipe tobacco smoking: A pilot randomized clinical trial. Addict Behav 78:94-100
Swain, Yayi; Muelken, Peter; LeSage, Mark G et al. (2018) Locomotor activity does not predict individual differences in morphine self-administration in rats. Pharmacol Biochem Behav 166:48-56
Chernick, Dustin; Ortiz-Valle, Stephanie; Jeong, Angela et al. (2018) High-density lipoprotein mimetic peptide 4F mitigates amyloid-?-induced inhibition of apolipoprotein E secretion and lipidation in primary astrocytes and microglia. J Neurochem 147:647-662
Claborn, Kasey R; Meier, Ellen; Miller, Mary Beth et al. (2018) Improving adoption and acceptability of digital health interventions for HIV disease management: a qualitative study. Transl Behav Med 8:268-279
Swalve, Natashia; Smethells, John R; Younk, Rebecca et al. (2018) Sex-specific attenuation of impulsive action by progesterone in a go/no-go task for cocaine in rats. Psychopharmacology (Berl) 235:135-143

Showing the most recent 10 out of 261 publications